dexcom g5tm rtcgm Search Results


dexcom g5tm rtcgm  (Dexcom Inc)
86
Dexcom Inc dexcom g5tm rtcgm
Forest plots of randomised controlled trials that compared continuous glucose monitoring vs. blood glucose monitoring for (A) HbA1c (%), (B) time in range (%), (C) time below range (<3.9 mmol/L) (%), (D) time below range (<3.0 mmol/L) (%), (E) time above range (>10 mmol/L) (%), (F) time above range (>13.9 mmol/L) (%) and (G) coefficient of variability. *, Wada, 2020 data for 1F is % TAR (>13.3 mmol/L). CGM, continuous glucose monitoring; isCGM, intermittently scanned CGM; <t>rtCGM,</t> real‐time CGM; BGM, blood glucose monitoring; HbA1c, glycated haemoglobin; TAR, time above range.
Dexcom G5tm Rtcgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexcom+g5tm+rtcgm/dexcom+g6+rtcgm+system/pmc12515760-175-13-13
Average 86 stars, based on 1 article reviews
dexcom g5tm rtcgm - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


Forest plots of randomised controlled trials that compared continuous glucose monitoring vs. blood glucose monitoring for (A) HbA1c (%), (B) time in range (%), (C) time below range (<3.9 mmol/L) (%), (D) time below range (<3.0 mmol/L) (%), (E) time above range (>10 mmol/L) (%), (F) time above range (>13.9 mmol/L) (%) and (G) coefficient of variability. *, Wada, 2020 data for 1F is % TAR (>13.3 mmol/L). CGM, continuous glucose monitoring; isCGM, intermittently scanned CGM; rtCGM, real‐time CGM; BGM, blood glucose monitoring; HbA1c, glycated haemoglobin; TAR, time above range.

Journal: Diabetes, Obesity & Metabolism

Article Title: Continuous glucose monitoring in noninsulin‐treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta‐analysis of randomised controlled trials

doi: 10.1111/dom.70008

Figure Lengend Snippet: Forest plots of randomised controlled trials that compared continuous glucose monitoring vs. blood glucose monitoring for (A) HbA1c (%), (B) time in range (%), (C) time below range (<3.9 mmol/L) (%), (D) time below range (<3.0 mmol/L) (%), (E) time above range (>10 mmol/L) (%), (F) time above range (>13.9 mmol/L) (%) and (G) coefficient of variability. *, Wada, 2020 data for 1F is % TAR (>13.3 mmol/L). CGM, continuous glucose monitoring; isCGM, intermittently scanned CGM; rtCGM, real‐time CGM; BGM, blood glucose monitoring; HbA1c, glycated haemoglobin; TAR, time above range.

Article Snippet: Cox and colleagues randomised noninsulin‐using individuals living with T2DM to an intervention using Dexcom G5TM rtCGM plus a GEM programme that incorporated 4 sessions of diabetes education along with one‐week periods of rtCGM‐derived feedback on postprandial changes.

Techniques: